Abstract
Felice Crocetto, Matteo Ferro, Gianluigi Carbone, Mariano Fiorenza, Rosa Sirica, Maria Perito, Carmela Polito, Michele Cennamo, Francesco Del Giudice, Daniela Terracciano
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024
European study of prostate cancer screening - 23-year Follow-up
10.1056/nejmoa2503223 · 2025
Racial differences in prostate cancer characteristics and cancer-specific mortality: an overview
10.5534/wjmh.210070 · 2022
Why do African-American men face higher risks for lethal prostate cancer?
10.1097/mou.0000000000000951 · 2022
Racial disparities in low-risk prostate cancer
10.1001/jama.2019.2060 · 2019
Prostate cancer genetic risk and associated aggressive disease in men of African ancestry
10.1038/s41467-023-43726-w · 2023
Prostate cancer characteristics in a multiracial community
10.1016/j.eururo.2007.04.048 · 2008
Evaluation of social determinants of health and prostate cancer outcomes among black and white patients: a systematic review and meta-analysis
10.1001/jamanetworkopen.2022.50416 · 2023
Prostate cancer disparities in black men of African descent: a comparative literature review of prostate cancer burden among black men in the United States, Caribbean, United Kingdom, and West Africa
2009
Evidence for clinically significant prostate cancer, overdiagnosis, active surveillance, and PSA screening
10.1007/s00345-024-04905-6 · 2024
Prostate cancer: prostate health Index--improving screening in men with family history
10.1038/nrurol.2013.169 · 2013
Optimizing prostate cancer care: clinical utility of the prostate health index
10.1002/pros.70025 · 2025
Performance of prostate health index in biopsy naive black men
10.1097/ju.0000000000001453 · 2021
Re-thinking how we use prostate health index for African American men
10.1016/j.urology.2022.12.057 · 2023
Reducing prostate cancer disparities for black men
10.1056/evide2400065 · 2024
Serum estrogen, but not testosterone, levels differ between black and white men in a nationally representative sample of Americans
10.1210/jc.2007-0028 · 2007
High circulating estrogens and selective expression of ERbeta in prostate tumors of Americans: implications for racial disparity of prostate cancer
10.1093/carcin/bgt156 · 2013
Oestrogens and prostate cancer: novel concepts about an old issue
10.1016/j.eururo.2008.12.004 · 2009
Estrogens and their receptors in prostate cancer: therapeutic implications
10.3389/fonc.2018.00002 · 2018
Estrogen receptor signaling in prostate cancer: implications for carcinogenesis and tumor progression
10.1002/pros.23446 · 2018
Aggressive prostate cancer is prevented in ERalphaKO mice and stimulated in ERbetaKO TRAMP mice
10.1210/en.2012-1030 · 2012
Effects of estrogen receptor signaling on prostate cancer carcinogenesis
10.1016/j.trsl.2020.04.003 · 2020
Dysregulation of estrogen signaling and HSD17B7 in the prostate stroma of African American men
10.1210/endocr/bqag017 · 2026
Estrogen-related receptor alpha (ERRalpha) controls the stemness and cellular energetics of prostate cancer cells via its direct regulation of citrate metabolism and zinc transportation
10.1038/s41419-025-07460-z · 2025
Lower PHI, [-2]proPSA/fPSA and testosterone/estradiol ratios in healthy black men: preliminary results and potential implications in prostate cancer clinical management
10.23736/s2724-6051.24.05667-2 · 2025
Racial disparities in prostate cancer: a complex interplay between socioeconomic inequities and genomics
10.1016/j.canlet.2022.01.028 · 2022
Prostate-specific antigen testing as part of a risk-adapted early detection strategy for prostate cancer: European association of urology position and recommendations for 2021
10.1016/j.eururo.2021.07.024 · 2021
Clinical validation of the prostate health index for detecting clinically significant prostate cancer in a population-based screening program
10.1111/iju.70409 · 2026
Concerns regarding prostate cancer screening guidelines in minority populations
10.1038/s41391-023-00765-0 · 2024
Inequalities in health literacy between European population and newly arrived male sub-saharan migrants in Europe
10.1093/heapro/daae129 · 2024
The PROCAN-B study protocol: early diagnosis of PROstate CANcer for black men-a community-centred participatory approach in Scotland and the North-East of England
10.1371/journal.pone.0315288 · 2024
A mixed-methods evaluation of a peer-led, co-produced, asset-based intervention for early diagnosis of prostate cancer for Black men: the PROCAN-B study
10.1136/bmjopen-2025-105803 · 2025
No additional external references are available.